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Structural Basis for Autoinhibition of the EphB2
Receptor Tyrosine Kinase by the Unphosphorylated
Juxtamembrane Region
analysis of the isolated kinase domain of the insulin
receptor has revealed how the activation segment can
control tyrosine kinase activity. In the inactive state,
Tyr1162 in the activation segment protrudes into the
active site, and blocks ATP binding (Hubbard et al.,
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1994). In the active state, autophosphorylated Tyr1162Mount Sinai Hospital
and adjacent residues reposition the activation seg-600 University Avenue
ment, thereby freeing the active site to engage sub-Toronto, Ontario M5G 1X5
strates and reorganizing catalytic residues into a func-Canada
tional conformation (Hubbard, 1997).2 Department of Molecular and Medical Genetics
It remains possible that other mechanisms are impor-University of Toronto
tant in regulating RTK activity. Indeed, there are prece-Toronto, Ontario M5S 1A8
dents for the regulation of other classes of protein ki-Canada
nases by polypeptide regions outside the catalytic
domain including the control of the type I TGF- receptor
(TGFR1) serine/threonine kinase by its juxtamembraneSummary
segment (Huse et al., 1999), and of Src family kinases
by flanking SH3, SH2, and C-terminal regions (SicheriThe Eph receptor tyrosine kinase family is regulated by
et al., 1997; Xu et al., 1997). Recent biochemical andautophosphorylation within the juxtamembrane region
mutational analysis has suggested that Eph receptors,and the kinase activation segment. We have solved
which represent the largest class of vertebrate RTK’s,the X-ray crystal structure to 1.9 A˚ resolution of an
may be regulated by their juxtamembrane region (Binnsautoinhibited, unphosphorylated form of EphB2 com-
et al., 2000; Zisch et al., 1998, 2000).prised of the juxtamembrane region and the kinase
Eph receptors fall into two groups, A and B, baseddomain. The structure, supported by mutagenesis
on their ability to bind ligands (ephrins), which are them-data, reveals that the juxtamembrane segment adopts
selves cell surface proteins anchored to the plasmaa helical conformation that distorts the small lobe of
membrane either through a GPI linkage (A-type) or athe kinase domain, and blocks the activation segment
transmembrane region (B-type) (Eph Nomenclaturefrom attaining an activated conformation. Phosphory-
Committee, 1997; Gale et al., 1996). Signaling betweenlation of conserved juxtamembrane tyrosines would
Eph receptors and ephrins generally involves direct cell-relieve this autoinhibition by disturbing the association
cell interactions (Holland et al., 1996; Bruckner et al.,of the juxtamembrane segment with the kinase do-
1997), and frequently results in cell repulsion (Dreschermain, while liberating phosphotyrosine sites for bind-
et al., 1995; Mellitzer et al., 1999). Vertebrate Eph recep-ing SH2 domains of target proteins. We propose that
tors have numerous functions in directed cell move-the autoinhibitory mechanism employed by EphB2 is
ments, in the formation of cell boundaries, and in thea more general device through which receptor tyrosine
morphogenesis of complex tissues such as the brainkinases are controlled.
and cardiovasculature system (Holder and Klein, 1999).
The extracellular region of Eph receptors contains anIntroduction
N-terminal ephrin binding domain, followed by a cyste-
ine-rich region and two fibronectin type III repeats. A
Receptor tyrosine kinases (RTKs) mediate the biological
single membrane-spanning sequence is followed by a
effects of numerous extracellular signaling proteins, and
juxtamembrane region (49 to 65 residues in EphB2 de-
thereby regulate many aspects of normal cellular behav- pending on the splice variant), an uninterrupted kinase
ior (van der Geer and Hunter, 1994). The binding of an domain, an -helical sterile  motif (SAM) domain impli-
extracellular ligand to a RTK induces either receptor cated in receptor oligomerization (Stapleton et al., 1999;
oligomerization or a spatial reorganization of pre-associ- Thanos et al., 1999), and a C-terminal PDZ domain bind-
ated receptor chains (Heldin, 1995; Schlessinger, 2000). ing motif. Activation of receptors such as EphB2 or
As a result, the receptor undergoes intermolecular auto- EphA4 is accompanied by autophosphorylation on mul-
phosphorylation, both on residues which regulate ki- tiple residues, including two tyrosines within a highly
nase activity and on tyrosine residues in noncatalytic conserved juxtamembrane motif (YIDPFTYEDP in EphB2)
regions of the receptor which form binding sites for and a tyrosine in the kinase activation segment (Dodelet
cytoplasmic targets with SH2 or PTB domains (Pawson and Pasquale, 2000). By analogy with other RTKs, it
and Scott, 1997; Kuriyan and Cowburn, 1997). might be expected that autophosphorylation of the acti-
The activity of tyrosine kinases is frequently stimu- vation segment tyrosine would stimulate kinase activity,
lated by autophosphorylation within a region of the ki- while the juxtamembrane phosphotyrosine sites would
nase domain termed the activation segment (Weinnmas- recruit cytoplasmic targets. Indeed, the juxtamembrane
ter et al., 1984; Hubbard and Till, 2000). Structural phosphotyrosine motifs do bind SH2 domain signaling
proteins (Dodelet and Pasquale, 2000), and substitution
of conserved juxtamembrane tyrosines in EphB2 with3 Correspondence: pawson@mshri.on.ca (T.P.), sicheri@mshri.on.ca
(F.S.) phenylalanine abrogates EphB2-mediated growth cone
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Table 1. Data Collection, Structure Determination, and Refinement Statistics
SeMet MAD Analysis Native
1  0.9790 A˚ 2  0.9788 A˚ 3  0.9770 A˚ (AMP-PNP)
Spacegroup P21 P21 P21 P1
Resolution (A˚) 2.3 2.3 2.3 1.9
Reflections total/unique 185034/52252 188170/52750 186452/52855 80035/43865
Completeness (%)a 97.5 (91.2) 97.6 (91.7) 97.6 (90.8) 90.3 (55.9)
Rsym (%)a,b 7.4 (26.2) 7.5 (27.9) 8.5 (38.7) 3.3 (14.6)
I/a 15.6 (4.0) 16.1 (3.9) 14.9 (3.1) 20.9 (4.1)
Phasing Power c (ISO/ANO) 0/2.59 2.71/4.11 2.08/3.40 —
Refinement (AMP-PMP Complex)
Resolution Range (A˚) 30–1.9 Average B value (A˚2) 24.9
Reflections Rmsd for B values (A˚2) 1.42
All data 42903 Rmsd for bonds (A˚) 0.007
|F|  2 39931 Rmsd for angles () 1.09
Rfactor/Rfree (%)d
All data 24.1/27.7 Number of nonhydrogen protein atoms 4311
|F|  2 23.2/26.9 Number of nonhydrogen nucleotide atoms 20
Residues in disallowed/most favored 0%/90.8% Number of water molecules 263
regions of the Ramachandran plot
a Numbers given in parentheses refer to data for the highest resolution shell.
b Rsym  100 	 
|I  I|/
I, where I is the observed intensity and I is the average intensity from multiple observations of symmetry-
related reflections.
c Phasing power for isomorphous and anomalous acentric reflections, where Ppower  [|Fh(calc)/phase-integrated lack of closure].
d Free R value was calculated with 8.7% of the data.
collapse in neuronal cells. However, this loss of biologi- latter half of the juxtamembrane region and the entire
catalytic domain was expressed as a GST fusion in E.cal activity is not due solely to a failure to engage SH2-
containing targets since substitution of the juxtamem- coli and purified to homogeneity (see Experimental Pro-
cedures). The predicted boundaries of the juxtamem-brane tyrosines in EphB2 and EphA4 with phenylalanine
leads to a severe loss of ephrin-induced kinase activity brane region are residues 573–620, while those of the
kinase and SAM domains are residues 621–892 and resi-(Binns et al., 2000).
Analysis of EphA4 in vitro kinase activity has sug- dues 919–994, respectively. The EphB2 crystal structure
reported here corresponds to the juxtamembrane-cata-gested that Eph receptor activation requires a two step
mechanism involving autophosphorylation of both the lytic domain fragment in complex with AMP-PNP (,-
imidoadenosine-5-triphosphate). Overall, the EphB2kinase domain activation segment and the juxtamembrane
tyrosines (Binns et al., 2000). Although substitution of the structure is well ordered except for the first seven and
last six amino acids, kinase domain residues 651 to 653juxtamembrane tyrosines with phenylalanine does not in-
fluence ATP binding, the mutant protein shows a 10- connecting  strands 2 and 3, and residues 774 to 796
corresponding to the kinase activation segment. Onlyfold decrease in its ability to phosphorylate a peptide
substrate, as compared to wild-type EphA4. Here, we the adenine ring of AMP-PNP is ordered and hence the
sugar and phosphate groups have not been modeled.have solved the X-ray crystal structure of the EphB2
kinase domain and juxtamembrane region in the autoin- Data collection and refinement statistics are listed in
Table 1, and a representative alignment of the EphB2hibited state. In its unphosphorylated form, the juxta-
membrane region adopts a helical structure that im- receptor and other protein kinase family members is
provided in Figure 1.pinges on the ordering of the activation segment and
distorts the conformation of the small lobe of the kinase
domain, thereby disrupting the active site. The structure Overall Description of the Autoinhibited Structure
also suggests how phosphorylation of the juxtamem- The structure of the catalytic domain of EphB2 conforms
brane tyrosines would relieve this autoinhibition. These to that generally observed for protein kinases, con-
results indicate a novel mechanism for the regulation of sisting of two lobes, a smaller N-terminal lobe and a
RTKs, which may be a target for oncogenic activation larger C-terminal lobe (Figures 2a and 2b). Protein ki-
in human cancers. nases are capable of a range of conformations owing
to an inherent interlobe flexibility that allows for both
open and closed conformations. However, the catalyti-Results
cally competent conformation is generally a closed
structure in which the two lobes clamp together to formStructure Determination
We have focused our crystallographic efforts on the an interfacial nucleotide binding site and catalytic cleft.
The autoinhibited EphB2 catalytic domain adopts acatalytically repressed Tyr604/610 Phe double mutant.
For the purpose of discussion, we refer to these sites closed conformation that superficially resembles an ac-
tive state.as Tyr/Phe604 and Tyr/Phe610. A cytoplasmic fragment
(residues 595 to 906) of murine EphB2 consisting of the The N-terminal lobe of protein kinases consists mini-
EphB2 Juxtamembrane Region—A Regulatory Switch
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Figure 1. Structure-Based Sequence Alignment of the Juxtamembrane Segments and Kinase Domains of Murine and Human EphB2, Murine
EphA4 and cAPK, and Human IRK, FGFR1, Hck, Kit, PDGFR, and Flt3
The secondary structure elements of murine EphB2 are indicated, with the juxtamembrane segment, the N-terminal kinase, the g loop, and
the C-terminal lobe colored red, green, orange, and blue, respectively. Residues Phe620 and Tyr750 and those marked with a star are involved
in the juxtamembrane/kinase domain interface. The two juxtamembrane tyrosines (604 and 610) that were mutated to phenylalanine are
highlighted in light blue. Additional tyrosines identified by Kalo and Pasquale (1999) as in vivo phosphorylation sites are highlighted in purple.
The solid triangle indicates the site of a 16 amino acid insertion in chicken EphB2 resulting from alternate RNA processing (Connor and
Pasquale, 1995). For Kit and PDGFR, tyrosines highlighted in yellow denote autophosphorylation sites, while sites of activating point mutations
and deletions are shaded gray (Tsujimura et al., 1996; Irusta and DiMaio, 1998; Kitayama et al., 1995; Hirota et al., 1998). The locations and
regions of duplicated sequence for activating Flt3 mutations are indicated by solid black triangles and underlining (Hayakawa et al., 2000).
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Figure 2. Overview of the Autoinhibited EphB2 Structure
(a) Ribbon diagram of the EphB2 crystal structure in complex with AMP-PNP. The juxtamembrane region, N-terminal kinase lobe, C-terminal
kinase lobe, and g loop are colored red, green, blue, and orange, respectively. Phosphoregulatory residues Tyr/Phe604 and Tyr/Phe610 are
colored light blue, Tyr667 is colored purple, and the adenine moiety of AMP-PNP is colored red. (b) Ribbon representation of EphB2 colored
as in (a), rotated 90 about the vertical axis. (c) and (d) Stereo magnification of the juxtamembrane regions in (a) and (b), respectively. Carbon,
oxygen, nitrogen, and sulfur atoms are shown in yellow, red, blue, and green, respectively. Residues involved in the juxtamembrane/kinase
domain interface but not shown include Ala616, Ala621, Leu676, Leu693, and Val696. All ribbon diagrams were prepared with RIBBONS
(Carson, 1991).
mally of a twisted 5-strand  sheet (denoted 1 to 5) -phosphate to a substrate oriented by the C-terminal
lobe. In this regard,  strands 1 and 2 and the glycine-and a single helix C (Knighton et al., 1991). The
N-terminal lobe functions to assist in the binding and rich connecting segment (g loop) form a flexible flap
that interacts with the adenine base, ribose sugar, andcoordination of ATP for the productive transfer of the
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the nonhydrolyzable phosphate groups of ATP. Further- the cleft region between the N- and C-terminal lobes
(Figures 2c and 2d). The phosphoregulatory residue Tyr/more, an invariant salt bridge between a lysine side
chain in  strand 3 and a glutamic acid side chain in Phe604 orients into a solvent-exposed hydrophobic
pocket composed of the side chains of Met748 andhelix C coordinates the -phosphate of ATP. In the
EphB2 crystal structure, all N-terminal lobe elements Tyr750 of the C-terminal kinase lobe, Ile681 and Phe685
from helix C, and Pro607 from the juxtamembrane heliximplicated in nucleotide binding are well ordered and
adopt a prototypical protein kinase arrangement. How- A. We have termed this site “switch region 1” since
Tyr/Phe604 appears well placed to influence the associ-ever, distortions in helix C and the g loop arising from
interactions with the juxtamembrane segment are ev- ation of the juxtamembrane region with the catalytic
domain. Further stabilizing the interaction of strand Ex1ident.
The C-terminal lobe of protein kinases consists mini- with the lower catalytic lobe are hydrogen bonds be-
tween the amide group of Tyr/Phe604 and the carbonylmally of two  strands (7 and 8) and a series of 
helices (D to I). Strands 7 and 8 locate to the cleft group of Met748 and between the side chain of Gln684
and the backbone amide and carbonyl groups of Ile605.region between the N- and C-terminal lobes where they
contribute side chains that participate in catalysis and Helix A is composed of a single rigid turn initiated
by Asp606 Pro607 and terminated by Thr609. A shortthe binding of magnesium for the coordination of ATP
phosphate groups. In the EphB2 crystal structure, all linker and then a three-turn helix B initiated by Asp612
Pro613 and extending to Phe620 follow helix A. Heli-lower lobe residues implicated in catalysis and ATP co-
ordination appear optimally oriented (Figure 3c). The ces A and B form an interface with the N-terminal
lobe of the kinase that centers on helix C. Hydrophobicactivation segment, which is also located in the large
catalytic lobe, is disordered as in several other protein side chains projecting from A and B include Pro607,
Phe608, Pro613, Val617, Phe620, and Ala621. These res-kinase structures in which the activation segment is not
phosphorylated (Johnson et al., 1996). The remaining idues associate with Arg673, Leu676, and Ile681 from helix
C and Leu693 and Val696 from  strand 4. In addition,C-terminal lobe elements, including  helices D to I,
are well ordered and the kinase terminates with a short a hydrogen bond interaction (2.9 A˚) is observed between
Asn614 and Arg672 (Figure 2c), and the small side chainshelix J.
The EphB2 juxtamembrane region preceding the cata- at positions 616 (Ala), 677 (Ser), and 680 (Ser) facilitate
the close packing of helices A, B, and C.lytic domain is highly ordered and adopts an identical
conformation in the four unique environments sampled Opposite to, but contiguous with, the site of associa-
tion with helix C, strand Ex1 and helices A and Bin the two different crystal forms studied. From the N
terminus, the conformation consists of an extended form an interface composed primarily of hydrophobic
interactions. The side chain of the phosphoregulatorystrand segment Ex1, a single turn 3/10 helix A, and a
four-turn helix B. These elements associate intimately residue Tyr/Phe610 projects onto the surface of this site
and appears well positioned to exert an influence on thewith helix C of the N-terminal catalytic lobe and also
make limited interactions with the C-terminal lobe. As local juxtamembrane structure. This interface, termed
“switch region 2,” is composed of the side chains ofa consequence of the association of the juxtamembrane
segment with the N-terminal kinase lobe, significant cur- Ile605 from strand Ex1 and the side chains of Ala616
and Phe620 from helix B.vature is imposed on helix C. This distortion couples
to local distortions in other N-terminal lobe elements,
most critically the g loop and the invariant lysine-gluta- Effect of the Juxtamembrane Engagement
mate salt bridge. Together, the N-terminal lobe distor- on the N-Terminal Lobe Structure
tions appear to impinge on catalytic function by ad- Comparison of the EphB2 crystal structure with that
versely affecting the coordination of the sugar and of the “active” triply phosphorylated insulin receptor
phosphate groups of the bound nucleotide. tyrosine kinase (active IRK [Hubbard, 1997]) indicates the
With limited contacts to the lower lobe of the catalytic mechanism by which the juxtamembrane region of EphB2
domain, the juxtamembrane segment also sterically im- inhibits the catalytic domain. Superposition of C-terminal
pedes the activation segment from adopting the pro- kinase lobe elements places the majority of N-terminal
ductive conformation that typifies the active state of lobe elements into close correspondence (Figures 3a–
protein-serine/threonine and tyrosine kinases. Together, 3d). A distinguishing feature of the EphB2 structure is
the effects on nucleotide coordination and the activation a 14 kink midway along helix C centered at Glu678.
segment form the basis for autoinhibition of EphB2 by This kink, which coincides with the site of association
the juxtamembrane segment. with the juxtamembrane elements Ex1, A, and B,
Depending on the splice variant of EphB2, there are displaces the forward facing N terminus of helix C
29–45 juxtamembrane residues between the start of 6.8 A˚ upward and outward from the equivalent position
strand Ex1 (Lys602) and the plasma membrane (Connor observed in IRK (Figures 3a and 3c). Stabilizing this
and Pasquale, 1995). This relatively lengthy sequence kink internally are side chain/main chain interactions
makes it impossible to predict whether the autoinhibited involving Ser677 and Ser680.
structure observed here would be oriented in a specific The kink in helix C places its forward projecting ter-
fashion with respect to the inner surface of the mem- minus in close proximity to  strands 3, 4, and 5, forming
brane. a tighter interface than that observed in active IRK (Fig-
ure 3b). Residues participating in this interface include
Arg672, Phe675, and Leu676 from helix C, Tyr667 fromDetailed Analysis of Juxtamembrane Structure
The juxtamembrane strand segment Ex1, corresponding the 3/C linker, and Leu663, Val696, Thr698, Val703,
and Ile705 from the  strands.to amino acid residues Lys602 to Ile605, extends along
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Figure 3. Comparison of Autoinhibited EphB2
RTK with the Active Insulin Receptor Kinase
(a) Superposition of EphB2 with active insulin
receptor kinase (Protein Data Bank ID code
1ir3). The backbone of the juxtamembrane
region of EphB2 is shown in red, with the
side chains of Tyr/Phe604 and Tyr/Phe610
colored light blue. The EphB2 kinase domain,
g loop, and bound adenine moiety are colored
blue, orange, and red, respectively. The back-
bone of active IRK is colored dark green with
its activation segment, g loop, and bound nu-
cleotide shown in purple, pink, and light
green, respectively. The two receptors were
aligned using all elements of the C-terminal
lobes except the kinase insert region, the ac-
tivation segment, helix J, and the C-terminal
tail (rms fit  1.91 A˚). (b) Stereo view of the
region noted in (a), with EphB2 phosphoryla-
tion sites shown in purple, other atoms col-
ored as in Figures 2c and 2d, and IRK side
chains shown in green and pink. (c) Stereo
view of the region noted in (a), highlighting
the kinase catalytic region. (d) Stereo view
of the region noted in (a) highlighting switch
region 1. Inactive IRK (Protein Data Bank ID
code 1irk), shown in yellow, is superimposed.
All side chains are colored according to their
respective backbones. IRK residue labeled
Thr776 corresponds to Ser776 in EphB2.
The close association of helix C with  strands 3, 4, chain atoms at the end of the g loop (Glu639 and Phe640)
by approximately 3.3 A˚. In addition, together with theand 5 is achieved with a local alteration to the twist of
the forward projecting termini of  strands 1, 2, and 3 kink in helix C, the altered twist of the  strands dis-
places the invariant glutamate and lysine side chains bythat leaves the bulk of the N-terminal sheet structure
unperturbed. The g loop side chain Phe640 plays a role 2.4 and 2.1 A˚, respectively, relative to their positions in
active IRK (Figure 3c). As a consequence, the abilityin coupling the  strand movements to that of helix C
through a direct interaction with Phe675. The altered of the catalytic domain to coordinate the sugar and
phosphate groups of bound nucleotide is compromisedtwist of the 1, 2, and 3 strand termini displace main
EphB2 Juxtamembrane Region—A Regulatory Switch
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(Figures 3a–3c). Since the domain closure and the bulk
of the N-terminal  sheet structure is not perturbed, the
adenine binding pocket is well formed and indeed the
adenine base of bound AMP-PNP is ordered and orients
in a manner similar to that in the crystal structure of
active IRK.
Steric Influence of the Juxtamembrane Region
on the Activation Segment
Strand Ex1 forms a limited set of interactions with the
C-terminal lobe that may serve a regulatory role. Super-
position of EphB2 with active IRK illustrates how the
side chain of the phosphoregulatory residue Tyr/Phe604
impedes the activation segment from adopting a pro-
ductive conformation (Figure 3d). In autoinhibited
EphB2, the side chain of Tyr750 adopts an alternate
conformation from that of the corresponding residue
Phe1128 in active IRK. This avoids a steric clash with the
side chain of Tyr/Phe604. The alternate conformation of
Tyr750, in turn, impedes the activation segment from
adopting a path observed in active IRK due to a steric
clash with Ser776 (Thr1154 in IRK). Interestingly, the
side chain conformation of Tyr750 in EphB2, Tyr382 in
Src and Hck, and Phe1128 in IRK all correlate with their
activation segments adopting nonproductive conforma-
tions. This may be indicative of a more general function
in protein kinases for position 750 in regulating the con-
Figure 4. Electrostatic Surface Representation of EphB2formation of the activation segment.
Blue and red regions indicate positive and negative potential, re-
spectively (10 to 10 kBT). Phosphoregulatory residues Tyr/Phe604
and Tyr/Phe610 are colored light blue. The molecular surface of
The Phosphoregulatory Switch EphB2 is oriented as in Figure 2a and was generated using GRASP
In EphB2, EphA4, and most likely Eph RTKs in general, (Nicholls et al., 1991).
the switch to an active state is coordinated by phosphor-
ylation at highly conserved sites within both the juxta-
membrane region and the catalytic domain. The mecha- electrostatic forces (Figure 4). The electrostatic environ-
nism by which phosphorylation at sites within the ment around “switch region 2” is also dominated by
activation segment stimulate protein kinases is relatively negatively charged amino acids, namely Asp606,
well understood (Johnson et al., 1996) and by inference, Glu611, Asp612, Glu615, and Glu619. Thus, phosphory-
phosphorylation of EphB2 at Tyr788 likely promotes the lation of Tyr610 would also generate repulsive electro-
ordering of the activation segment to a catalytically com- static forces, which are likely essential for the expulsion
petent conformation. In contrast, phosphorylation at of this residue from its binding pocket since a phosphate
Tyr/Phe604 and 610 may serve to destabilize the juxta- group could be accommodated sterically.
membrane structure and cause it to dissociate from the Three other highly conserved tyrosine residues (667,
catalytic domain. This would allow for a return of the 744, and 750) have been identified as in vivo phosphory-
N-terminal lobe to an undistorted active conformation. lation sites in EphB2 and EphB5 (Kalo and Pasquale,
The EphB2 crystal structure helps to explain how 1999). Although their roles in regulating Eph receptor
phosphorylation at each of the two phosphoregulatory kinase activity are unknown, all three sites appear well
sites could destabilize the juxtamembrane structure and positioned to influence the stability of the autoinhibited
cause its release from the catalytic domain. The environ- structure and hence Eph receptor activity (Figure 3). For
ment around each of the two switch regions is hydropho- example, phosphorylation of Tyr667 could promote a
bic, but solvent exposed, and thus could accommodate catalytically competent state by destabilizing the tight
either tyrosine or phenylalanine at positions 604 and association of helix C with  strands 3, 4, and 5 ob-
610 with little or no reorganization of the juxtamembrane served in the autoinhibited state. In addition, phosphory-
structure. However, accommodation of phosphotyro- lation of Tyr744 and Tyr750, which line the cleft region
sine appears less tolerable due to steric and electro- through which the juxtamembrane strand Ex1 navigates,
static clashes involving the bulky anionic phosphate could amplify the effect of phosphorylation at Tyr604.
group. In “switch region 1,” the phosphorylation of Tyr/ It remains to be determined how Eph receptor binding
Phe604 would place a phosphate group within van der to ephrins on the outside of the cell facilitates autophos-
Waals contact of Asp606, Pro607, and Ile681. Further- phorylation within the cell. One possibility is that recep-
more, the side chain of Asp606 dominates the electro- tor ligation serves simply to raise the local concentration
static environment around Tyr/Phe604 such that the in- of receptor chains thereby promoting transphosphoryla-
tion. Indeed, overexpression of EphB2 in cell lines istroduction of a phosphate group would generate repulsive
Cell
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sufficient for constitutive receptor activation, in contrast catalytic function as measured by the spectrophotomet-
ric assay to 136% and 216% of wild-type activity in theto the ephrin-dependent activation observed in cells
case of the JX1 and the JX12 deletions, respec-expressing physiological levels of EphB2 (Binns et al.,
tively. A similar effect was observed for the JX122000). Alternatively, the physical force of receptor clus-
deletion introduced into full-length EphB2.tering may destabilize the autoinhibitory juxtamembrane
Mutation of Phe608 in EphA4, which locates to helixconformation and thereby initiate receptor activation.
A, gave very weak restoration of catalytic function.However, the variable length and poorly conserved na-
This result is consistent with the variability of positionture of the polypeptide sequence connecting the trans-
608 amongst the Eph receptor family members (42%membrane segment to the ordered part of the juxta-
identity). In contrast, mutation in both EphA4 and EphB2membrane segment makes it hard to predict whether
constructs of the highly conserved Pro607 (95% iden-clustering through the extracellular region would impact
tity), which initiates helix A, to Gly greatly enhancedintracellular structure. More experiments are required
catalytic function in all four assays, quantitated at 122%to resolve this issue.
of wild-type activity by the spectrophotometric assay.
This result is consistent with a role for Pro607, sug-Function of the EphA4 Juxtamembrane Segment
gested by the crystal structure, in stabilizing helix AProbed by Mutagenesis
by imposing conformational rigidity, or in promoting theThe mechanism of autoinhibition suggested by the
association of juxtamembrane and N-terminal kinaseEphB2 crystal structure is consistent with previous data
lobe elements through hydrophobic interactions. Simi-showing that autophosphorylation on both juxtamem-
larly, mutation of the highly conserved Phe620 (95%brane and kinase activation segment tyrosines is re-
identity) at the terminus of helix B to Asp also restoredquired for maximal activation. In order to test our crystal-
catalytic function in the four assays tested. Phe620 islographic findings in more detail, we have generated
notable because it contributes to the hydrophobicadditional site-directed mutations in the full-length mu-
pocket into which the phosphoregulatory residue Tyr/rine EphB2 receptor expressed in COS-1 cells and in a
Phe610 binds; its substitution with Asp is predicted tomurine EphA4 receptor fragment expressed in bacteria,
disrupt the hydrophobic interaction with Tyr/Phe610,corresponding in content to the EphB2 construct used
and to clash electrostatically with the surrounding nega-for the structure determination. We have employed the
tively charged groups in a manner mimicking phosphor-murine EphB2 numbering scheme for all mutants gener-
ylation of Tyr610.ated. Each mutation was generated in the fully repressed
The introduction of point mutations into the kinaseTyr604/610 Phe double mutant background and was
domain at the interface with the juxtamembrane region
tested for its ability to restore catalytic function. The
also restored catalytic function. Mutation of Ser680
mutations include a small N-terminal deletion of resi-
(82% identity) to Trp in both EphA4 and EphB2 con-
dues 599 to 606 (JX1) encompassing strand Ex1 and
structs gave modest restoration with the phosphoryla-
the first phosphoregulatory site, an intermediate N-ter-
tion of peptide substrate being restored to 41% of wild-
minal deletion of residues 599 to 610 (JX12) encom-
type activity. Mutation of the absolutely conserved
passing strand Ex1, the first phosphoregulatory site, Gln684 (100% identity) to Trp in EphB2 resulted in a
helix A, and the second phosphoregulatory site, and greater increase in kinase activity, as did the double
a full juxtamembrane segment deletion of residues 599 mutation Ser680Trp/Gln684Trp. Both mutations map to
to 621 (JXall). In addition, six separate point mutants helix C and are predicted to sterically perturb the asso-
were generated in both the juxtamembrane region and ciation of the juxtamembrane region with the N-terminal
the kinase domain (Pro607Gly, Phe608Asp, Phe620Asp, catalytic lobe.
Tyr604/610Glu, Ser680Trp, Gln684Trp) that were pre- Robust restoration of activity was also observed for
dicted to destabilize the interaction of the kinase domain the EphA4 and EphB2 mutants JXall, Tyr604/610Glu,
with the juxtamembrane segment. Lastly, the JX12 and JX12 plus Phe620Asp, although the relative res-
mutation was combined with the Phe620Asp mutation toration as measured by the various assays differed to
(JX12 plus Phe620Asp) and the Ser680Trp mutation a small degree. The restoration of activity by the JXall
was combined with the Gln684Trp mutation (Ser680Trp/ mutant confirms that the juxtamembrane segment is not
Gln684Trp). The Tyr604/610Phe double mutant and the absolutely required for kinase function, the restoration
wild-type proteins were analyzed concomitantly as ref- by the Tyr604/610Glu mutation suggests that the addi-
erence points for the fully repressed (0%) and active tion of negative charges at positions 604 and 610 is an
(100%) states, respectively. The activities of the EphA4 important component of juxtamembrane destabilization
proteins expressed in bacteria were tested for their abil- and the relief of autoinhibition. Lastly, the finding that
ity to induce protein tyrosine phosphorylation in vivo none of the EphB2 mutants are as active as the wild-type
(Figure 5a), and to autophosphorylate and to phosphory- enzyme may indicate that these mutants have perturbed
late enolase in vitro (Figure 5b). EphA4 proteins were some aspect of the oligomerization event that is needed
also tested for their ability to phosphorylate a peptide for maximal activation of the full-length receptor.
substrate using a continuous spectrophotometric assay Overall, the mutagenesis results support a model for
(Figure 5c). Lastly, full-length EphB2 proteins expressed the regulation of receptor catalytic function by the juxta-
in COS-1 cells were tested for their ability to autophos- membrane segment shown in Figure 6. Strand Ex1 and
phorylate in vivo and to autophosphorylate and phos- helix A of the juxtamembrane segment contribute to
phorylate enolase in vitro (Figure 5d). the inhibitory effect on the catalytic domain, and the
The two partial N-terminal juxtamembrane deletions release of these elements from their association with the
when introduced into the EphA4 construct significantly catalytic domain is a requirement for catalytic activation.
Physiologically, this would be accomplished by phos-increased kinase activity in all four assays, restoring
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Figure 5. Comparison of the Kinase Activities of EphA4 and EphB2 Wild-Type and Mutant Proteins
(a) GST-EphA4 proteins were expressed in E. coli, and cell lysates were subjected to immunoblot analysis with anti-pTyr antibody (top panel)
and anti-GST antibody (lower panel).
(b) Equal quantities of GST-EphA4 proteins bound to glutathione sepharose were assessed for their ability to autophosphorylate and phosphory-
late enolase by an in vitro kinase assay (top panel). Immunoblot analysis of GST-EphA4 proteins with anti-GST antibody (lower panel).
(c) Histogram of the specific activities of EphA4 wild-type and mutant proteins as measured by the spectrophotometric coupling assay at 1
mM S-1 peptide and 0.5 M EphA4 proteins. The velocities represent the mean of triplicate reactions and have been normalized to the specific
activity of wild-type EphA4 (top panel). Coomassie stained SDS-PAGE analysis of EphA4 proteins (lower panel).
(d) EphB2 and its mutants were expressed in COS-1 cells and immunoprecipitated. The immunoprecipitates were resolved by SDS-PAGE,
immunoblotted with anti-pTyr (top panel) or anti-EphB2 (middle panel) antibodies, and assessed for their ability to autophosphorylate and
phosphorylate enolase by an in vitro kinase assay (bottom panel).
phorylation at the Tyr604 and 610 regulatory sites and and/or conformation of helix C. Beyond these similari-
ties, however, the inhibitory mechanisms, including thepotentially at additional sites. The strong conservation
of residues involved in the inhibitory interaction sug- mode of juxtamembrane association with the catalytic
domain and the resulting basis for inhibition, diverge.gests that this regulatory mechanism is conserved for
all Eph receptor family members. Perhaps the most significant difference relates to the
potential involvement of FKBP12 in stabilizing the inhib-
ited structure of TGFR1, whereas EphB2 achieves anComparison of Autoinhibitory Mechanisms
of EphB2 and TGFR1 Receptor Kinase autoinhibited state independently. Nonetheless, our
data for EphB2 suggest that receptor tyrosine kinasesAnalysis of the TGFR1 serine/threonine kinase has re-
vealed a role for the juxtamembrane “GS” segment in and receptor serine/threonine kinases have in some
cases converged on a related regulatory mechanismregulating catalytic activity. As with Eph receptor tyro-
sine kinases, TGFR1 kinases require phosphorylation in which the juxtamembrane region inhibits the kinase
domain in the inactive state, and is potentially liberatedat sites within the juxtamembrane segment for subse-
quent phosphorylation of target Smad proteins (Macias- to interact with downstream targets upon autophos-
phorylation.Silva et al., 1996). The regulatory mechanism revealed
by the X-ray crystal structure of a cytoplasmic fragment
of TGFR1 in complex with FKBP12 (Huse et al., 1999) Discussion
shows some parallels to EphB2. In both structures, the
intramolecular engagement of the juxtamembrane seg- Why does EphB2 employ a rather complex mechanism
of autoregulation, involving the noncatalytic juxtamem-ment induces conformational distortions in the catalytic
domain that impinge on kinase function. In addition, the brane region? One possible benefit may be to block
signaling activity intrinsic to the juxtamembrane se-induced distortions impact on the relative positioning
Cell
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Figure 6. Schematic Diagram Highlighting Difference between the Autoinhibited and Active States of the Eph Receptor Family of Tyrosine
Kinases
The active configuration is based on the crystal structure of active IRK (Protein Data Bank ID 1ir3). Dashed lines indicate regions of activation
segment disorder. The numbering scheme corresponds to murine EphB2.
quence. In particular, phosphorylation of tyrosines 604 factor-1 receptor (c-Fms), stem cell factor receptor (Kit),
and the Flt3 receptor suggest that catalytic regulationand 610 in EphB2 creates docking sites for SH2 domain
proteins. Sequestering these tyrosines decreases their by the juxtamembrane region may also be a widespread
phenomenon. In PDGFR-, autophosphorylation of jux-chance of becoming adventitiously phosphorylated and
thereby inappropriately transmitting a signal through the tamembrane tyrosines 579 and 581 is required for stimu-
lation of receptor kinase activity by PDGF (Baxter et al.,recruitment of downstream targets. The coordination of
kinase activation with the release of binding sites for 1998). Conversion of these juxtamembrane tyrosines to
phenylalanine inhibits receptor activation, while substi-targets is reminiscent of the Src family cytoplasmic tyro-
sine kinases, in which the SH2 and SH3 domains engage tution of a valine residue, just N-terminal to the regula-
tory tyrosines, results in constitutive receptor activationinternal ligands in a fashion that both inhibits the activity
of the kinase domain and hinders interactions of the SH2 in vitro and in vivo (Irusta and DiMaio, 1998). Furthermore,
phosphorylation of juxtamembrane tyrosines creates aand SH3 domains with other binding partners (Sicheri et
al., 1997; Xu et al., 1997). binding site for the Src SH2 domain, resulting in Src
recruitment to the receptor. The juxtamembrane regionsThe involvement of the juxtamembrane sequence in
autoregulation of EphB2 activity may also set a phos- of the c-Fms (Myles et al., 1994), Kit, and Flt3 receptors
have also been implicated in regulation of tyrosine ki-phorylation threshold that must be exceeded to induce
receptor activation. Full stimulation of Eph receptors nase activity. Oncogenic variants of Kit identified in hu-
man and murine mast cell leukemias carry either aminoapparently requires autophosphorylation at multiple
sites, minimally within the activation segment and the acid substitutions or deletions in the juxtamembrane
region, which result in constitutive activation of the ki-juxtamembrane region. The use of at least two distinct
phosphoregulatory steps may preclude inappropriate nase domain (Tsujimura et al., 1996) (see Figure 1). Re-
markably, a majority of human gastrointestinal stromalEph receptor activation resulting from basal levels of
kinase activity. tumors (GIST) have activating Kit mutations that intro-
duce substitutions or deletions into a short segment ofAre the Eph receptors unique among RTKs in employing
cytoplasmic elements outside the catalytic domain to the juxtamembrane region, and are strongly implicated
in the etiology of these tumors (Hirota et al., 1998; Naka-regulate kinase activity? Data for the platelet-derived
growth factor -receptor (PDGFR), colony stimulating hara et al., 1998; Anderson, 1998). Furthermore, approxi-
EphB2 Juxtamembrane Region—A Regulatory Switch
755
and Bricogne, 1997) and SnB (Miller et al., 1994) were used in combi-mately 20% of acute myeloid leukemias have internal
nation to locate and refine 22 of the 30 Se sites. Following densitytandem duplications of Flt3 that create in-frame inser-
modification with Solomon (Abrahams and Leslie, 1996), a partialtions of variable length in the juxtamembrane region,
model was generated using O (Jones et al., 1991) and refined using
leading to ligand-independent kinase activity and onco- CNS (Brunger et al., 1998) (R factor  40%). Consequently, crystals
genic activation (Nakao et al., 1996; Yokota et al., 1997; of EphB2 in complex with 2 mM AMP-PNP were grown as described
above (space group  P1, a  47.05 A˚, b  57.62 A˚, c  67.74 A˚,Hayakawa et al., 2000). These data suggest that the Kit
  112.95,   103.17,   91.58, with two molecules per asym-and Flt3 juxtamembrane regions repress kinase activity,
metric unit). Diffraction data was collected to 1.9 A˚ at APS beamlineand that juxtamembrane mutations that relieve this inhi-
BM 14-C (  1.00 A˚) using a Quantum 4 ADSC CCD detectorbition can result in human cancers. It will be of interest to
and processed with the HKL program suite. Molecular replacement
determine whether the juxtamembrane regions of these solutions were determined with AMoRe (Navaza, 1994; CCP4, 1994),
receptors adopt an autoinhibitory conformation, and using one monomer of the P21-derived model as a search molecule.
With minimal modification to the starting model, the model has beenwhether it is similar to that of EphB2.
refined to a working R value of 24.1% and a free R value of 27.7%.Many RTKs have C-terminal tails that upon activation
Pertinent statistics for data collection and refinement are shown inbecome phosphorylated at SH2/PTB domain binding
Table 1.sites. Structural analysis of the Tie2/Tek receptor cyto-
plasmic region shows that in the inactive state, the tail
Mutagenesis
interacts with the kinase domain in a way that partially The cDNA sequence of the juxtamembrane region and kinase do-
occludes the C-terminal tyrosines and the peptide bind- main of murine EphA4 (amino acids 591–896), corresponding to
residues 599–906 of murine EphB2, was cloned into pGEX4T-2 (Phar-ing site (Shewchuk et al., 2000). This raises the possibil-
macia). We employ the murine EphB2 numbering scheme, and listity that autophosphorylation of the Tie2 tail causes a
the corresponding EphA4 residue numbers in parentheses. Usingconformational change that exposes both C-terminal
a PCR-based approach, Tyr604 (Tyr596) and Tyr610 (Tyr602) werephosphotyrosine sites as well as the substrate binding
mutated to phenylalanine. The following site-directed mutants were
site of the kinase domain. Thus, the juxtamembrane and then generated using this doubly mutated construct: (1) JXall; dele-
C-terminal segments of RTKs may in some cases play tion of 599–621 (591–613), (2) JX1; deletion of 599–606 (591–598),
(3) JX12; deletion of 599–610 (591–602), (4) Pro607Gly (Pro599-a pivotal role in regulating the kinase domain, and in
Gly), (5) Phe608Asp (Phe600Asp), (6) Phe620Asp (Phe612Asp), (7)coordinating enzymatic activation with the exposure of
Ser680Trp (Ser672Trp), (8) JX12 plus Phe620Asp, and (9) Tyr604/motifs that bind cytoplasmic targets.
610Glu (Tyr596/602Glu). The GST-EphA4 constructs were trans-In addition to revealing an unexpected level of com-
formed into E. coli BL21 codon plus cells and grown in LB supple-
plexity in the regulation of RTKs, these observations mented with ampicillin, with overnight induction at 15C, and 0.15
have interesting implications for the design of RTK inhib- mM IPTG. Purification was performed for mutants (2)–(7) as de-
scribed for EphB2. The mutations Tyr604Phe, Tyr610Phe, Pro607-itors. The structure of the Abl kinase bound to the inhibi-
Gly, Phe620Asp, Ser680Trp, Gln684Trp, deletion of 599–606 (JX1),tor STI-571 suggests that this compound binds selec-
deletion of 599–610 (JX12), and deletion of 600–621 (JXall) intively to the inactive form of the kinase (Schindler et
murine EphB2 were generated by site-directed mutagenesis usingal., 2000). The unusual structure of autoinhibited EphB2
overlapping oligonucleotide primers containing the above indicated
suggests the possibility of isolating inhibitors that bind point mutations or deletions. All mutations were confirmed by DNA
specifically to the inactive conformation of the kinase. sequencing.
Indeed, if this mode of intrasteric regulation is a more
Western Blottingcommon feature of RTKs, this might be a general strat-
GST-EphA4 proteins expressed in E. coli (BL21 codon plus), andegy for the identification of selective RTK inhibitors.
EphB2 proteins transiently expressed in COS-1 cells, were har-
vested as previously described (Binns et al., 2000; Holland et al.,Experimental Procedures
1997). Proteins were resolved using 12% denaturing polyacryla-
mide gel electrophoresis (PAGE), transferred onto a polyvinylideneProtein Expression and Purification
difluoride membrane (Millipore), blotted with anti-pTyr (Upstate Bio-Mutagenesis of the juxtamembrane tyrosines (Y604/610F) of murine
technology), anti-GST (Santa Cruz Laboratories), or anti-EphB2 anti-EphB2 was performed using a PCR-based approach. The amplified
bodies (Holland et al., 1997), and visualized using enhanced chemi-cDNA sequence, corresponding to the receptor’s juxtamembrane
luminescence (ECL Plus; Amersham).region and kinase domain (residues 595–906), was cloned into
pGEX-4T-1 (Pharmacia). The glutathione S-transferase (GST)-
In Vitro Kinase ReactionsEphB2 construct was transformed into Escherichia coli B834 cells
In vitro kinase reactions using GST fusion EphA4 proteins boundand the cells grown in minimal media supplemented with seleno-
to glutathione sepharose or immunoprecipitated EphB2 proteinsmethionine, with overnight induction at 15C, and 0.15 mM IPTG
transiently expressed in COS-1 cells were performed with 5 g and(isopropyl--D-thiogalactopyranoside, BioShop). Purification of the
2 g of acid-denatured enolase, respectively, and 5 Ci of [32P]ATPselenomethionyl derivative of EphB2 was performed as previously
at room temperature as previously described (Binns et al., 2000).described (Binns et al., 2000).
In Vitro Spectrophotometric Coupling AssayCrystallization, Data Collection, and Structure Determination
Kinetic analysis of the bacterial expressed EphA4 proteins was per-Hanging drops containing 1 l of 12.5 mg/ml protein were mixed
formed using a coupled spectrophotometric kinase assay (Barkerwith equal volumes of reservoir buffer containing 0.1 M HEPES (pH
et al., 1995) as described previously (Binns et al., 2000). Wild-type7.0), 0.2 M magnesium chloride, 10% (w/v) PEG 4000, 10% (v/v)
and mutant EphA4 activity was measured by monitoring absorbanceisopropanol, and 15% (v/v) ethylene glycol. Crystals of the space
at 340 nm of reaction mixtures with 0.5 M kinase concentrationgroup P21 (a  47.86 A˚, b  98.09 A˚, c  68.18 A˚,     90,  
and 1 mM S-1 peptide (GEEIYGEFD; amide at carboxyl terminus).104.97), with two molecules of EphB2 in the asymmetric unit, were
obtained at 28C. A MAD experiment was performed on a frozen
crystal at APS beamline BM 14-D (1  0.9790 A˚, 2  0.9788 A˚, Acknowledgments
3  0.9770 A˚) using a Quantum 4 ADSC CCD detector. Data pro-
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